Net Cash Provided by (Used in) Operating Activities |
200 |
USD |
|
Q3 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
|
Q3 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q3 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
1M |
shares |
0% |
Q4 2022 |
Q2 2023 |
Common Stock, Shares, Issued |
101M |
shares |
+11812% |
Q1 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-170 |
USD |
+98.4% |
Q3 2022 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
124 |
USD |
+520% |
Q1 2024 |
Q3 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q3 2023 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
54.3K |
USD |
+121% |
Q2 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
54.3K |
USD |
+121% |
Q2 2023 |
FY 2023 |
Depreciation |
3.93K |
USD |
|
Q1 2023 |
Q3 2023 |
Additional Paid in Capital |
125K |
USD |
+257% |
Q1 2024 |
Q3 2024 |
Depreciation, Depletion and Amortization |
0 |
USD |
-100% |
Q1 2024 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2023 |
FY 2023 |